R&D Bringing therapies to patients quicker with integrated CDMO ... Biotechs and pharmaceutical companies can receive enormous value from a trusted partnership with an integrated CDMO and CRO.
R&D Seamless scale-up: Integrated manufacturing becomes the biop... Today, the demand for speed, quality, and scalability is pushing the industry towards a different model: integrated manufacturing.
Partner Content Partner Content Trio of Senior Hires Joins Syneos Health Global Communicatio... Strengthened Communications Leadership Team to Enhance Integrated Communications Solutions for Customers in the UK and Across Europe
Partner Content Partner Content INC Research/inVentiv Health Becomes Syneos Health New Identity Signifies Industry’s Only Fully Integrated, End-to-End Biopharmaceutical Solutions Organization
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.